Physician profile
Argirios Mantzoukas
NPI 1134297542
$445.70
in general payments reported to CMS, 2019-2025
8 companies · $18.30 in 2025
The $18.30 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $40.17 · 2021: $145 · 2022: $136 · 2025: $18.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $18.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $18.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $136.36 | 2022 | |
| Abbvie INC. | $122.43 | 2021 | |
| Smith+Nephew, INC. | $84.58 | 2019-2020 | |
| Sandoz INC. | $42.78 | 2020-2021 | |
| Baxter Healthcare | $18.30 | 2025 | |
| Gotham Surgical Solutions & Devices, INC. | $18.00 | 2019 | |
| Wright Medical Technology, INC. | $11.70 | 2019 | |
| Pfizer INC. | $11.55 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Argirios Mantzoukas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.